Suppr超能文献

采用不同技术和不同透析膜的慢性血液透析患者的C反应蛋白

C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.

作者信息

Panichi V, Rizza G Manca, Taccola D, Paoletti S, Mantuano E, Migliori M, Frangioni S, Filippi C, Carpi A

机构信息

Department of Internal Medicine, University of Pisa, Italy.

出版信息

Biomed Pharmacother. 2006 Jan;60(1):14-7. doi: 10.1016/j.biopha.2005.06.013. Epub 2005 Oct 25.

Abstract

In hemodialysis patients, C-reactive protein (CRP), an acute-phase reactant, is a sensitive and independent marker of malnutrition, anemia, and cardiovascular mortality. The aim of the present study was to evaluate CRP levels in plasma samples from long-term hemodialysis patients on different extracorporeal modalities and dialyzed with different membranes, at baseline and after 6 months. Two hundred and forty-seven patients were recruited in eight hospital-based centers. All patients had been on their dialytic modality for at least 3 months and were prospectively followed in their initial dialytic modality for 6 months. Patients were treated with conventional bicarbonate dialysis (N = 127) or hemodiafiltration (N = 120). Patients treated with conventional bicarbonate dialysis were dialyzed with different membranes: Cuprophane (N = 51), low-flux cellulose modified membrane (N = 37) and synthetic membranes (N = 39). Hemodiafiltration was performed in post-dilution mode with polysulfone (N = 66) and polyacrylonitrile (N = 54) membranes. Analysis of baseline CRP values in the clinically stable patients showed that an unexpectedly high proportion (47%) of the patients had CRP values higher than 5 mg/l (upper limit in normal subjects). The mean +/- S.D. CRP values were significantly higher (P < 0.05) in hemodiafiltration with infusion volumes < 10 l per session (14.6+/-3.1 mg/l) than in standard hemodialysis (5.1 +/- 2.1 mg/l) and hemodiafiltration with infusion volumes > 20 l per session (4.9 +/- 2.1 mg/l). These values did not significantly change after 6 months of follow-up. Concerning the membranes, the highest levels of CRP were observed in patients dialyzed with Cuprophane with a significant increase from 15.1 +/- 3.6 to 21.2 +/- 3.1 mg/l after 6 months (P < 0.05); a significant reduction of CRP levels was observed in patients dialyzed with polysulfone in the same follow-up period (from 13.5 +/- 2.9 to 8.1 +/- 2.4 mg/l; P < 0.05). The CRP increase following low volume HDF can be related to back-filtration of bacterial derived contaminants.; moreover, an important effect on CRP of the hemodialysis membrane is observed and new synthetic membranes can be used to decrease these levels.

摘要

在血液透析患者中,C反应蛋白(CRP)作为一种急性期反应物,是营养不良、贫血及心血管疾病死亡率的敏感且独立的标志物。本研究旨在评估长期血液透析患者在不同体外循环模式下,使用不同透析膜,于基线期及6个月后的血浆样本中CRP水平。在8个医院中心招募了247例患者。所有患者接受其透析模式至少3个月,并在初始透析模式下前瞻性随访6个月。患者接受常规碳酸氢盐透析(N = 127)或血液透析滤过(N = 120)治疗。接受常规碳酸氢盐透析的患者使用不同的透析膜:铜仿膜(N = 51)、低通量纤维素改性膜(N = 37)和合成膜(N = 39)。血液透析滤过采用后稀释模式,使用聚砜膜(N = 66)和聚丙烯腈膜(N = 54)。对临床稳定患者的基线CRP值分析显示,出乎意料的是,相当高比例(47%)的患者CRP值高于5mg/l(正常受试者上限)。每次透析液输注量<10L的血液透析滤过组的平均±标准差CRP值(14.6±3.1mg/l)显著高于标准血液透析组(5.1±2.1mg/l)和每次透析液输注量>20L的血液透析滤过组(4.9±2.1mg/l)(P<0.05)。随访6个月后,这些值无显著变化。关于透析膜,使用铜仿膜透析的患者CRP水平最高,6个月后从15.1±3.6mg/l显著升高至21.2±3.1mg/l(P<0.05);在同一随访期内,使用聚砜膜透析的患者CRP水平显著降低(从13.5±2.9mg/l降至8.1±2.4mg/l;P<0.05)。低容量血液透析滤过后CRP升高可能与细菌衍生污染物的逆向滤过有关;此外,观察到血液透析膜对CRP有重要影响,新型合成膜可用于降低这些水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验